Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status. [electronic resource]
Producer: 20161213Description: 435-42 p. digitalISSN:- 1600-0609
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anemia -- etiology
- Calreticulin -- genetics
- Child
- Female
- Follow-Up Studies
- Gene Expression
- Humans
- Janus Kinase 2 -- genetics
- Male
- Middle Aged
- Mutation
- Platelet Aggregation Inhibitors -- administration & dosage
- Primary Myelofibrosis -- etiology
- Quinazolines -- administration & dosage
- Receptors, Thrombopoietin -- genetics
- Retrospective Studies
- Thrombocythemia, Essential -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.